Sanofi
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!About SNY
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines.
CEOPaul Hudson
CEOPaul Hudson
Employees84,587
Employees84,587
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded1994
Founded1994
Employees84,587
Employees84,587
SNY Key Statistics
Market cap119.05B
Market cap119.05B
Price-Earnings ratio20.10
Price-Earnings ratio20.10
Dividend yield3.31%
Dividend yield3.31%
Average volume2.27M
Average volume2.27M
High today$49.00
High today$49.00
Low today$48.28
Low today$48.28
Open price$48.70
Open price$48.70
Volume1.56M
Volume1.56M
52 Week high$60.12
52 Week high$60.12
52 Week low$45.80
52 Week low$45.80
SNY News
TipRanks 1d
Regeneron and Sanofi’s Dupilumab Study: A Potential Game-Changer for Pediatric AsthmaRegeneron Pharmaceuticals ((REGN)), Sanofi SA ((SNY)), Sanofi ((DE:SNW)), Sanofi ((SNYNF)) announced an update on their ongoing clinical study. Don’t Miss TipR...
TipRanks 2d
Regeneron and Sanofi’s Expanded Access Program for Dupilumab: A Potential Market MoverRegeneron Pharmaceuticals ((REGN)), Sanofi SA ((SNY)), Sanofi ((SNYNF)), Sanofi ((DE:SNW)) announced an update on their ongoing clinical study. Don’t Miss TipR...
TipRanks 2d
Sanofi’s Innovative Approach in RRMM Treatment: A Closer Look at the Latest Clinical StudySanofi SA ((SNY)), Sanofi ((SNYNF)), Sanofi ((DE:SNW)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage...
Analyst ratings
76%
of 25 ratingsBuy
76%
Hold
24%
Sell
0%
More SNY News
TipRanks 3d
Sanofi’s Riliprubart Gains Orphan Drug Status in US and JapanDon’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...